Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

UAC increased production of military transport aircraft by 30%

12/29/23 UNAC

United Medical Group re-registered in the Russian jurisdiction

12/29/23 GEMC

VTB to receive ₽112 billion in dividends from Otkritie

12/29/23 VTBR

Nauka reported for 9 months of 2023 by RAS

12/29/23 NAUK

SPB Exchange invites shareholders to the EGM

12/29/23 SPBE

SPB Exchange resumes trading

12/29/23 SPBE

Board of Directors of Samolet approved the buyback for next year

12/29/23 SMLT

Gazprom built the fourth line of the Amur Gas Processing Plant

12/29/23 GAZP

SPB Exchange reported suspension of trading due to technical failure

12/29/23 SPBE

VTB may conduct a reverse split of shares

12/29/23 VTBR